Simcere Pharmaceutical Group Return on Assets:
1.60% for Dec. 31, 2012Simcere Pharmaceutical Group Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 1.60% |
| Sept. 30, 2012 | 3.38% |
| June 30, 2012 | 3.72% |
| March 31, 2012 | 5.10% |
| Dec. 31, 2011 | 5.23% |
| Sept. 30, 2011 | 5.95% |
| June 30, 2011 | 6.81% |
| March 31, 2011 | 5.76% |
| Dec. 31, 2010 | 5.58% |
| Sept. 30, 2010 | 1.31% |
| June 30, 2010 | 0.01% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
SCR Return on Assets Benchmarks
| Companies | |
|---|---|
| Bristol-Myers Squibb | 4.27% |
| Merck | 5.83% |
| Sagent Pharmaceuticals | 0.76% |
SCR Return on Assets Rankings
| Overall |
68th percentile 2517 of 8002 |
| Sector |
67th percentile 220 of 684 in Healthcare |
| Industry |
69th percentile 21 of 68 in Drug Manufacturers - Specialty & Generic |
SCR Return on Assets Range, Past 5 Years
| Minimum | -0.04% | Mar 2010 |
| Maximum | 14.81% | Jun 2008 |
| Average | 5.89% |
